Enhanced hepatocyte growth factor level in human prostate cancer treated with endocrine therapy

International Journal of Oncology

Volumn 13, Issue 1, 1998, Pages 169-176

  Tsuka, Harutoshi ^a   Mori, Hirotaka ^a   Li, Benyi ^a   Kanamaru, Hiroshi ^a   Matsukawa, Shigeru ^a   Okada, Kenichiro ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Competitive PCR; Hepatocyte growth factor; Western blot analysis

Indexed keywords

DNA; HORMONE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; SCATTER FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0031833812     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.1.169     Document Type: Article

References (27)

1. Matsumoto K, Nakamura T, Tsubouchi H, Gohda E, Strain AJ, Daikuhara Y, Michalopoulps GK, Appasamy R, Sciracher P, Geerts A, Jung W, Pietrangelo A, Rogler CE and Dienes HP: Organ regeneration. In: Hepatocyte Growth Factor-scatter Factor (HGF-SF) and the c-Met Receptor. Goldgerg ID and Rosen EM (eds). Birkhauser, Basal, pp225-299, 1993.
2. Rosen EM, Zitnik RJ, Elias JA, Bhargava MM, Wines J, Goldberg ID, Wiedner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W, Halaban R, Rubin JS, White W, Hashio K and Shima N: Tumor invasion and metastasis. In: Hepatocyte Growth Factor-scatter Factor (HGF-SF) and the c-Met Receptor. Goldgerg ID and Rosen EM (eds). Birkhauser, Basal, pp301-368, 1993.
3. Takahashi M, Ota S, Ogura M, Nakamura T and Omata M: Hepatocyte growth factor stimulates wound repair of the rabbit esophageal epithelial cells in primary culture. Biochem Biophys Res Commun 216: 298-305, 1995.
4. Tajima H, Matsumoto K and Nakamura T: Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell line. FEBS Lett 291: 229-232, 1991.
5. Shiota G, Bhoads DB, Wang TC, Nakamura T and Schmidt EV: Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 89: 373-377, 1992.
6. Nakamura T, Teramoto H and Ichihara A: Purification and characterization of hepatocyte growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83: 6489-6493, 1986.
7. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimanishi M, Sugimura A, Tashiro K and Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
8. Zarnegar R and DeFrances MC: Expression of HGF-SF in normal and malignant human tissues. In: Hepatocyte Growth Factorscatter Factor (HGF-SF) and the c-Met Receptor. Goldgerg ID and Rosen EM (eds). Birkhauser, Basal, pp181-199, 1993.
9. Chan AM-L, Rubison JS, Bottaro DP, Hirshfield DW, Chedid M and Aaronson SA: Identification of competitive HGF antagonist encoded by an alternative transcript. Science 254: 1382-1385, 1991.
10. Park M, Dean M, Kaul K, Braun MJ, Gonda MA and Vande Woude GF: Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptor. Proc Natl Acad Sci USA 84: 6379-6383, 1987.
11. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS and Comoglio PM: Tyrosine kinase receptor indistinguishable from the c-MET protein. Nature 339: 155-156, 1989.
12. Bottaro DP, Rubin JS, Falletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF and Aaronson SA: Identification of the hepatocyte growth factor receptor as c-met proto-oncogene product. Science 251: 802-804, 1991.
13. Schmidt G and Thannhauser SJ: A method for the determination of deoxyribonucleic acid, and phosphoproteins in animal tissues. J Biol Chem 161: 83-89, 1945.
14. Burton K: Determination of DNA concentration with diphenylamine. Methods Ezymol 12: 163-166, 1968.
15. Mejbaum W: Über die Bestimmung kleiner Pentosemengen, insbesondere in Deivation der Adenlysäure. Z Physiol Chem 258: 117-120, 1968.
16. Tsubouchi H, Nitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T and Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-liked immunosorbent assay. Hepatology 13: 1-5, 1991.
17. Sakaguchi H, Seki S, Tsubouchi H, Daikuhara Y, NitaniY and Kobayashi K: Ultastructural location of human hepatocyte growth factor in human liver. Hepatology 19: 1157-1163, 1994.
18. Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, Tsubouchi H and Daikuhara Y: Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 22: 1728-1734, 1995.
19. Humphrey PA, Zhu X, Zamegar R, Swanson PE, Ratliff TL, Vollmer RT and Day ML: Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147: 386-396, 1995.
20. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y and Kitamura N: Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 268: 10024-10028, 1993.
21. Nishi N, Oya H, Matsumoto K, Nakamura T, Miyanaka H and Wada F: Changes in gene expression of growth factors and their receptors during chastration-induced involution and androgen-induced regrowth of rat prostates. Prostate 28: 139-152, 1996.
22. Matsumoto K, Tajima H, Okazaki H and Nakamura T: Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β1 and glucocorticoids. J Biol Chem 267: 24917-24920, 1992.
23. Santoni-Rugiu E, Preisegger KH, Kiss A, Audolfsson T, Shiota, Schmidt EV and Thorgeisson SS: Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 93: 9577-9582, 1996.
24. Denmeade SR, Lin XS and Isaacs JT: Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 28: 251-265, 1996.
25. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC and Chung LWK: C-MET proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154: 293-298, 1995.
26. Morita M, Watanabe Y and Akane T: Protective effect of hepatocyte growth factor on interferon-y-induced cytotoxicity in mouse hepatocytes. Hepatology 21: 1585-1593, 1995.
27. Wollf HK, Zarnegar R and Michalopoulos GK: Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 14: 488-494, 1991.